Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.7K Sell
2,856
-29
-1% -$545 0.04% 245
2025
Q4
$45.1K Sell
2,885
-159
-5% -$2.36K 0.03% 271
2025
Q3
$40.3K Buy
3,044
+567
+23% +$7.33K 0.03% 298
2025
Q2
$30.8K Buy
2,477
+6
+0.2% +$76 0.02% 331
2025
Q1
$37.6K Sell
2,471
-120
-5% -$1.8K 0.03% 296
2024
Q4
$37.8K Buy
2,591
+9
+0.3% +$141 0.03% 298
2024
Q3
$41.2K Buy
2,582
+108
+4% +$1.92K 0.03% 291
2024
Q2
$47K Sell
2,474
-64
-3% -$1.2K 0.04% 250
2024
Q1
$49.5K Buy
2,538
+130
+5% +$2.42K 0.04% 243
2023
Q4
$48.8K Buy
+2,408
New +$47.3K 0.04% 232

Other funds holding NOV

Bruce G. Allen Investments's NOV Position: Q1 2026 in Review

Bruce G. Allen Investments reduced its NOV (NOV) stake by 1% in Q1 2026, selling an estimated $545 and leaving 2,856 shares worth $53.7K. The position accounts for 0.04% of the portfolio, ranked #245.

Bruce G. Allen Investments first reported a position in NOV in Q4 2023 and has held it in 10 quarters since. 463 funds tracked by Wall St. Rank hold NOV as of Q1 2026.

  • Bruce G. Allen Investments held 2,856 shares of NOV worth $53.7K as of Q1 2026.
  • Bruce G. Allen Investments sold 29 NOV shares in Q1 2026, an estimated $545.
  • NOV made up 0.04% of Bruce G. Allen Investments's portfolio in Q1 2026, its #245 holding.
  • Bruce G. Allen Investments first reported a position in NOV in Q4 2023 and has held it in 10 quarters since.
  • 463 funds tracked by Wall St. Rank held NOV as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.